0 Comments
0 Shares
150 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Alzheimer's Disease Diagnostic Market: How Is the Alzheimer's Diagnostic Market Being Transformed by New Treatments?FDA-approved amyloid-targeting therapies — lecanemab (Leqembi) and donanemab (Kisunla) receiving FDA approval for early AD treatment — have fundamentally transformed Alzheimer's diagnostics from a primarily academic exercise toward a clinically necessary component of treatment pathway qualification, with the Alzheimer's Disease Diagnostic Market reflecting the treatment-driven...0 Comments 0 Shares 22 Views 0 Reviews